{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T02:17:56Z","timestamp":1776737876864,"version":"3.51.2"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["TMA2018CDF-2351"],"award-info":[{"award-number":["TMA2018CDF-2351"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH NURTURE","award":["D43TW010132"],"award-info":[{"award-number":["D43TW010132"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11785-7","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:45:09Z","timestamp":1760525109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Performance evaluation of alternative bacteriological measures of response to MDR\/RR-TB therapy during the initial 16 weeks of treatment"],"prefix":"10.1186","volume":"25","author":[{"given":"Willy","family":"Ssengooba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Musisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derrick","family":"Semugenze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Komakech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moses","family":"Ndema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Sekaggya-Wiltshire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Adakun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek J.","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achilles","family":"Katamba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Lamorde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moses","family":"Joloba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilber","family":"Sabiiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"11785_CR1","unstructured":"WHO. Global tuberculosis report 2024: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2024 Accessed 22 November 2024. 2024."},{"key":"11785_CR2","unstructured":"WHO: World Health Organization. 2010. Multidrug and extensively drug-resistant tuberculosis (M\/XDR-TB): global report on surveillance and response. Geneva, Switzerland: WHO, 2010; http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599191_eng.pdf. 2010."},{"key":"11785_CR3","unstructured":"WHO. In: WHO consolidated guidelines on tuberculosis: Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update:. Geneva; 2022."},{"key":"11785_CR4","doi-asserted-by":"publisher","DOI":"10.3201\/eid2310.170468","author":"C Hewison","year":"2017","unstructured":"Hewison C, Ferlazzo G, Avaliani Z, Hayrapetyan A, Jonckheere S, Khaidarkhanova Z, et al. Six-Month response to Delamanid treatment in MDR TB patients. Emerg Infect Dis. 2017. https:\/\/doi.org\/10.3201\/eid2310.170468.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"11785_CR5","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1183\/13993003.00462-2016","volume":"48","author":"CD Mitnick","year":"2016","unstructured":"Mitnick CD, White RA, Lu C, Rodriguez CA, Bayona J, Becerra MC, et al. Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method. Eur Respir J. 2016;48(4):1160\u201370.","journal-title":"Eur Respir J"},{"issue":"6","key":"11785_CR6","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1586\/17476348.2016.1166960","volume":"10","author":"N Rockwood","year":"2016","unstructured":"Rockwood N, du Bruyn E, Morris T, Wilkinson RJ. Assessment of treatment response in tuberculosis. Expert Rev Respir Med. 2016;10(6):643\u201354.","journal-title":"Expert Rev Respir Med"},{"issue":"8","key":"11785_CR7","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1093\/cid\/ciu1153","volume":"60","author":"S Datta","year":"2015","unstructured":"Datta S, Sherman JM, Bravard MA, Valencia T, Gilman RH, Evans CA. Clinical evaluation of tuberculosis viability microscopy for assessing treatment response. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2015;60(8):1186\u201395.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"key":"11785_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4177","author":"ST Malherbe","year":"2016","unstructured":"Malherbe ST, Shenai S, Ronacher K, Loxton AG, Dolganov G, Kriel M, et al. Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure. Nat Med. 2016. https:\/\/doi.org\/10.1038\/nm.4177.","journal-title":"Nat Med"},{"key":"11785_CR9","doi-asserted-by":"crossref","unstructured":"Sabiiti W, Mtafya B, De Lima DA, Dombay E, Baron VO, Azam K, Oravcova K, Sloan DJ, Gillespie SH. A tuberculosis molecular bacterial load assay (TB-MBLA). J Vis Exp 2020(158).","DOI":"10.3791\/60460"},{"key":"11785_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-1-4939-7037-7_5","volume":"1616","author":"SH Gillespie","year":"2017","unstructured":"Gillespie SH, Sabiiti W, Oravcova K. Mycobacterial load assay. Methods Mol Biol. 2017;1616:89\u2013105.","journal-title":"Methods Mol Biol"},{"issue":"11","key":"11785_CR11","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1128\/JCM.00547-11","volume":"49","author":"I Honeyborne","year":"2011","unstructured":"Honeyborne I, McHugh TD, Phillips PP, Bannoo S, Bateson A, Carroll N, Perrin FM, Ronacher K, Wright L, van Helden PD, et al. Molecular bacterial load assay, a culture-free biomarker for rapid and accurate quantification of sputum Mycobacterium tuberculosis bacillary load during treatment. J Clin Microbiol. 2011;49(11):3905\u201311.","journal-title":"J Clin Microbiol"},{"key":"11785_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.954074","volume":"12","author":"C Nimmo","year":"2022","unstructured":"Nimmo C, Millard J, Faulkner V, Monteserin J, Pugh H, Johnson EO. Evolution of Mycobacterium tuberculosis drug resistance in the genomic era. Front Cell Infect Microbiol. 2022;12:954074.","journal-title":"Front Cell Infect Microbiol"},{"issue":"11","key":"11785_CR13","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.5588\/ijtld.21.0741","volume":"26","author":"SE Smith-Jeffcoat","year":"2022","unstructured":"Smith-Jeffcoat SE, Eisenach KD, Joloba M, Ssengooba W, Namaganda C, Nsereko M, et al. Quantification of multidrug-resistant M. tuberculosis bacilli in sputum during the first 8 weeks of treatment. Int J Tuberculosis Lung Disease: Official J Int Union against Tuberculosis Lung Disease. 2022;26(11):1058\u201364.","journal-title":"Int J Tuberculosis Lung Disease: Official J Int Union against Tuberculosis Lung Disease"},{"key":"11785_CR14","unstructured":"WHO: Guidelines for the programmatic management of drug-resistant tuberculosis, 2011 update. Geneva: World Health Organization. 2011 (WHO\/HTM\/TB\/2011.6; http:\/\/whqlibdoc.who.int\/publications\/2011\/9789241501583_eng.pdf, accessed 21 October 2024). 2011."},{"key":"11785_CR15","unstructured":"WHO: World Health Organization. Meeting report of the WHO expert consultation on drug-resistant tuberculosis treatment outcome definitions [Internet]. Geneva. 2021. [cited March 4, 2022]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240022195. Accessed 03 Dec, 2024. 2022."},{"key":"11785_CR16","unstructured":"Siddiqi S, R\u00fcsch-Gerdes SMGIT, Procedure Manual. For BACTEC\u2122 MGIT 960\u2122 TB System (Also applicable for Manual MGIT) Mycobacteria Growth Indicator Tube (MGIT) Culture and Drug Susceptibility Demonstration Projects, 2006. Available at: http:\/\/www.finddiagnostics.org\/export\/sites\/default\/resource-centre\/find_documentation\/pdfs\/mgit_manual_nov_2007.pdf"},{"key":"11785_CR17","unstructured":"WHO. Target product profile for tuberculosis diagnosis and detection of drug resistance: URL: https:\/\/www.who.int\/publications\/i\/item\/9789240097698. Accessed on 03 December 2024. 2024."},{"key":"11785_CR18","unstructured":"WHO: WHO operational handbook on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment: URL: https:\/\/iris.who.int\/bitstream\/handle\/10665\/332398\/9789240006997-eng.pdf. Accessed on 03 November 2024. 2020."},{"key":"11785_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-005357","author":"NE Ntinginya","year":"2021","unstructured":"Ntinginya NE, Kuchaka D, Orina F, Mwebaza I, Liyoyo A, Miheso B, et al. Unlocking the health system barriers to maximise the uptake and utilisation of molecular diagnostics in low-income and middle-income country setting. BMJ Glob Health. 2021. https:\/\/doi.org\/10.1136\/bmjgh-2021-005357.","journal-title":"BMJ Glob Health"},{"key":"11785_CR20","unstructured":"Global tuberculosis report. 2018. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO. URL; http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/274453\/9789241565646-eng.pdf?ua=1. Accessed 10th November 2018."},{"issue":"4","key":"11785_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(23)00367-1","volume":"5","author":"E Musisi","year":"2024","unstructured":"Musisi E, Wamutu S, Ssengooba W, Kasiinga S, Sessolo A, Sanyu I, et al. Accuracy of the tuberculosis molecular bacterial load assay to diagnose and monitor response to anti-tuberculosis therapy: a longitudinal comparative study with standard-of-care smear microscopy, Xpert MTB\/RIF ultra, and culture in Uganda. Lancet Microbe. 2024;5(4):e345\u201354.","journal-title":"Lancet Microbe"},{"key":"11785_CR22","doi-asserted-by":"crossref","unstructured":"Neumann M, Reimann M, Chesov D, Popa C, Dragomir A, Popescu O, Munteanu R, Holscher A, Honeyborne I, Heyckendorf J, et al. The Molecular Bacterial Load Assay predicts treatment responses in patients with pre-XDR\/XDR-tuberculosis more accurately than GeneXpert Ultra MTB\/Rif. J Infect. 2024;106399.","DOI":"10.1016\/j.jinf.2024.106399"},{"issue":"10","key":"11785_CR23","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.5588\/ijtld.11.0811","volume":"16","author":"EV Kurbatova","year":"2012","unstructured":"Kurbatova EV, Gammino VM, Bayona J, Becerra MC, Danilovitz M, Falzon D, et al. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2012;16(10):1335\u201343.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9","key":"11785_CR24","doi-asserted-by":"publisher","first-page":"650","DOI":"10.7326\/0003-4819-144-9-200605020-00008","volume":"144","author":"TH Holtz","year":"2006","unstructured":"Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V. Time to sputum culture conversion in Multidrug-Resistant tuberculosis: predictors and relationship to treatment outcome. Ann Intern Med. 2006;144(9):650\u20139.","journal-title":"Ann Intern Med"},{"issue":"4","key":"11785_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ijtb.2016.09.013","volume":"63","author":"AK Yadav","year":"2016","unstructured":"Yadav AK, Mehrotra AK, Agnihotri SP, Swami S. Study of factors influencing response and outcome of Cat-IV regimen in MDRTB patients. Indian J Tuberc. 2016;63(4):255\u201361.","journal-title":"Indian J Tuberc"},{"issue":"1","key":"11785_CR26","volume":"34","author":"R Ncha","year":"2019","unstructured":"Ncha R, Variava E, Otwombe K, Kawonga M, Martinson NA. Predictors of time to sputum culture conversion in multi-drug-resistant tuberculosis and extensively drug-resistant tuberculosis in patients at Tshepong-Klerksdorp hospital. South Afr J Infect Dis. 2019;34(1):111.","journal-title":"South Afr J Infect Dis"},{"key":"11785_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02927-20","author":"PM Mbelele","year":"2021","unstructured":"Mbelele PM, Mpolya EA, Sauli E, Mtafya B, Ntinginya NE, Addo KK, et al. Mycobactericidal effects of different regimens measured by molecular bacterial load assay among people treated for multidrug-resistant tuberculosis in Tanzania. J Clin Microbiol. 2021. https:\/\/doi.org\/10.1128\/JCM.02927-20.","journal-title":"J Clin Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11785-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11785-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11785-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:45:14Z","timestamp":1760525114000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11785-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11785"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11785-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5834681\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Makerere University School of Biomedical Sciences Research Ethics committee (SBS-REC #651) and the Uganda National Council for Science and Technology (UNCST #HS471ES). Our study adhered to the Declaration of Helsinki and the national guidelines. Eligible participants gave a written informed consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have declared that no competing interests exist.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1336"}}